Related Experiment Video
Updated: Aug 12, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling
Pilar Sanchez1, Ana Maria Hernández, Barbara Stecca
1Skirball Institute and Department of Cell Biology, New York University School of Medicine, 540 First Avenue, New York, NY 10016, USA.
Abstract:
Prostate cancer is the most common solid tumor in men, and it shares with all cancers the hallmark of elevated, nonhomeostatic cell proliferation. Here we have tested the hypothesis that the SONIC HEDGEHOG (SHH)-GLI signaling pathway is implicated in prostate cancer. We report expression of SHH-GLI pathway components in adult human prostate cancer, often with enhanced levels in tumors versus normal prostatic epithelia. Blocking the pathway with cyclopamine or anti-SHH antibodies inhibits the proliferation of GLI1+/PSA+ primary prostate tumor cultures. Inversely, SHH can potentiate tumor cell proliferation, suggesting that autocrine signaling may often sustain tumor growth. In addition, pathway blockade in three metastatic prostate cancer cell lines with cyclopamine or through GLI1 RNA interference leads to inhibition of cell proliferation, suggesting cell-autonomous pathway activation at different levels and showing an essential role for GLI1 in human cells. Our data demonstrate the dependence of prostate cancer on SHH-GLI function and suggest a novel therapeutic approach.
Insights
The SONIC HEDGEHOG (SHH)-GLI pathway drives prostate cancer growth. Inhibiting this pathway, crucial for cancer cell proliferation, offers a potential new therapeutic strategy for prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling Pathways
Background:
- Prostate cancer is the most common male cancer, characterized by uncontrolled cell proliferation.
- The SONIC HEDGEHOG (SHH)-GLI signaling pathway is a key regulator of cell growth and development.
Purpose of the Study:
- To investigate the role of the SHH-GLI signaling pathway in prostate cancer.
- To determine if targeting the SHH-GLI pathway can inhibit prostate cancer growth.
Main Methods:
- Examined expression of SHH-GLI pathway components in prostate tumors and normal tissues.
- Utilized cyclopamine and anti-SHH antibodies to block the SHH-GLI pathway in primary prostate tumor cultures.
- Employed GLI1 RNA interference and cyclopamine in metastatic prostate cancer cell lines.
Main Results:
- SHH-GLI pathway components are frequently upregulated in prostate tumors compared to normal tissue.
- Blocking the SHH-GLI pathway significantly inhibited proliferation in primary prostate tumor cultures.
- SHH-GLI pathway inhibition also reduced proliferation in metastatic prostate cancer cell lines, highlighting GLI1's essential role.
- Evidence suggests autocrine SHH signaling may promote tumor growth.
Conclusions:
- Prostate cancer growth is dependent on the SHH-GLI signaling pathway.
- Targeting the SHH-GLI pathway represents a promising novel therapeutic strategy for prostate cancer.
Related Concept Videos
Hedgehog Signaling Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Hedgehog Signaling Pathway

